487 related articles for article (PubMed ID: 27741949)
1. Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial.
Tongyoo S; Permpikul C; Mongkolpun W; Vattanavanit V; Udompanturak S; Kocak M; Meduri GU
Crit Care; 2016 Oct; 20(1):329. PubMed ID: 27741949
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome].
Lyu G; Wang X; Jiang W; Cai T; Zhang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261
[TBL] [Abstract][Full Text] [Related]
3. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.
Abraham E; Baughman R; Fletcher E; Heard S; Lamberti J; Levy H; Nelson L; Rumbak M; Steingrub J; Taylor J; Park YC; Hynds JM; Freitag J
Crit Care Med; 1999 Aug; 27(8):1478-85. PubMed ID: 10470753
[TBL] [Abstract][Full Text] [Related]
4. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome.
Annane D; Sébille V; Bellissant E;
Crit Care Med; 2006 Jan; 34(1):22-30. PubMed ID: 16374152
[TBL] [Abstract][Full Text] [Related]
5. Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.
Keh D; Trips E; Marx G; Wirtz SP; Abduljawwad E; Bercker S; Bogatsch H; Briegel J; Engel C; Gerlach H; Goldmann A; Kuhn SO; Hüter L; Meier-Hellmann A; Nierhaus A; Kluge S; Lehmke J; Loeffler M; Oppert M; Resener K; Schädler D; Schuerholz T; Simon P; Weiler N; Weyland A; Reinhart K; Brunkhorst FM;
JAMA; 2016 Nov; 316(17):1775-1785. PubMed ID: 27695824
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled pilot randomized trial of methylprednisolone infusion in pediatric acute respiratory distress syndrome.
Drago BB; Kimura D; Rovnaghi CR; Schwingshackl A; Rayburn M; Meduri GU; Anand KJ
Pediatr Crit Care Med; 2015 Mar; 16(3):e74-81. PubMed ID: 25634565
[TBL] [Abstract][Full Text] [Related]
7. [Risk factors of the occurence and death of acute respiratory distress syndrome: a prospective multicenter cohort study].
Ge Q; Yao Z; Wang T; Liu Z; Li A; Wang S; Li G; Bian W; Chen W; Yi L; Yang Z; Tao L; Zhu X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Nov; 26(11):773-9. PubMed ID: 25399889
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials.
Santhakumaran S; Gordon A; Prevost AT; O'Kane C; McAuley DF; Shankar-Hari M
Crit Care; 2019 May; 23(1):156. PubMed ID: 31053084
[TBL] [Abstract][Full Text] [Related]
9. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial.
Meduri GU; Headley AS; Golden E; Carson SJ; Umberger RA; Kelso T; Tolley EA
JAMA; 1998 Jul; 280(2):159-65. PubMed ID: 9669790
[TBL] [Abstract][Full Text] [Related]
10. A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome.
Khan A; Benthin C; Zeno B; Albertson TE; Boyd J; Christie JD; Hall R; Poirier G; Ronco JJ; Tidswell M; Hardes K; Powley WM; Wright TJ; Siederer SK; Fairman DA; Lipson DA; Bayliffe AI; Lazaar AL
Crit Care; 2017 Sep; 21(1):234. PubMed ID: 28877748
[TBL] [Abstract][Full Text] [Related]
11. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial.
Fowler AA; Truwit JD; Hite RD; Morris PE; DeWilde C; Priday A; Fisher B; Thacker LR; Natarajan R; Brophy DF; Sculthorpe R; Nanchal R; Syed A; Sturgill J; Martin GS; Sevransky J; Kashiouris M; Hamman S; Egan KF; Hastings A; Spencer W; Tench S; Mehkri O; Bindas J; Duggal A; Graf J; Zellner S; Yanny L; McPolin C; Hollrith T; Kramer D; Ojielo C; Damm T; Cassity E; Wieliczko A; Halquist M
JAMA; 2019 Oct; 322(13):1261-1270. PubMed ID: 31573637
[TBL] [Abstract][Full Text] [Related]
12. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group.
Anzueto A; Baughman RP; Guntupalli KK; Weg JG; Wiedemann HP; Raventós AA; Lemaire F; Long W; Zaccardelli DS; Pattishall EN
N Engl J Med; 1996 May; 334(22):1417-21. PubMed ID: 8618579
[TBL] [Abstract][Full Text] [Related]
13. Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial.
Heming N; Renault A; Kuperminc E; Brun-Buisson C; Megarbane B; Quenot JP; Siami S; Cariou A; Forceville X; Schwebel C; Leone M; Timsit JF; Misset B; Benali MA; Colin G; Souweine B; Asehnoune K; Mercier E; Chimot L; Charpentier C; François B; Boulain T; Petitpas F; Constantin JM; Dhonneur G; Baudin F; Combes A; Bohé J; Loriferne JF; Cook F; Slama M; Leroy O; Capellier G; Dargent A; Hissem T; Bounab R; Maxime V; Moine P; Bellissant E; Annane D; ;
Lancet Respir Med; 2024 May; 12(5):366-374. PubMed ID: 38310918
[TBL] [Abstract][Full Text] [Related]
14. Effect of Aspirin on Development of ARDS in At-Risk Patients Presenting to the Emergency Department: The LIPS-A Randomized Clinical Trial.
Kor DJ; Carter RE; Park PK; Festic E; Banner-Goodspeed VM; Hinds R; Talmor D; Gajic O; Ware LB; Gong MN;
JAMA; 2016 Jun; 315(22):2406-14. PubMed ID: 27179988
[TBL] [Abstract][Full Text] [Related]
15. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial.
Matthay MA; Calfee CS; Zhuo H; Thompson BT; Wilson JG; Levitt JE; Rogers AJ; Gotts JE; Wiener-Kronish JP; Bajwa EK; Donahoe MP; McVerry BJ; Ortiz LA; Exline M; Christman JW; Abbott J; Delucchi KL; Caballero L; McMillan M; McKenna DH; Liu KD
Lancet Respir Med; 2019 Feb; 7(2):154-162. PubMed ID: 30455077
[TBL] [Abstract][Full Text] [Related]
16. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.
Angstwurm MW; Engelmann L; Zimmermann T; Lehmann C; Spes CH; Abel P; Strauss R; Meier-Hellmann A; Insel R; Radke J; Schüttler J; Gärtner R
Crit Care Med; 2007 Jan; 35(1):118-26. PubMed ID: 17095947
[TBL] [Abstract][Full Text] [Related]
17. The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial.
Hager DN; Hooper MH; Bernard GR; Busse LW; Ely EW; Fowler AA; Gaieski DF; Hall A; Hinson JS; Jackson JC; Kelen GD; Levine M; Lindsell CJ; Malone RE; McGlothlin A; Rothman RE; Viele K; Wright DW; Sevransky JE; Martin GS
Trials; 2019 Apr; 20(1):197. PubMed ID: 30953543
[TBL] [Abstract][Full Text] [Related]
18. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature.
Meduri GU; Bridges L; Shih MC; Marik PE; Siemieniuk RAC; Kocak M
Intensive Care Med; 2016 May; 42(5):829-840. PubMed ID: 26508525
[TBL] [Abstract][Full Text] [Related]
19. Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial.
Asehnoune K; Seguin P; Allary J; Feuillet F; Lasocki S; Cook F; Floch H; Chabanne R; Geeraerts T; Roger C; Perrigault PF; Hanouz JL; Lukaszewicz AC; Biais M; Boucheix P; Dahyot-Fizelier C; Capdevila X; Mahe PJ; Le Maguet P; Paugam-Burtz C; Gergaud S; Plaud B; Constantin JM; Malledant Y; Flet L; Sebille V; Roquilly A;
Lancet Respir Med; 2014 Sep; 2(9):706-16. PubMed ID: 25066331
[TBL] [Abstract][Full Text] [Related]
20. Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis: The VICTAS Randomized Clinical Trial.
Sevransky JE; Rothman RE; Hager DN; Bernard GR; Brown SM; Buchman TG; Busse LW; Coopersmith CM; DeWilde C; Ely EW; Eyzaguirre LM; Fowler AA; Gaieski DF; Gong MN; Hall A; Hinson JS; Hooper MH; Kelen GD; Khan A; Levine MA; Lewis RJ; Lindsell CJ; Marlin JS; McGlothlin A; Moore BL; Nugent KL; Nwosu S; Polito CC; Rice TW; Ricketts EP; Rudolph CC; Sanfilippo F; Viele K; Martin GS; Wright DW;
JAMA; 2021 Feb; 325(8):742-750. PubMed ID: 33620405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
